@article {Booth571, author = {Crystal Booth}, title = {Investigating Aberrant Results in Microbiological Examination of Nonsterile Product Assays}, volume = {74}, number = {5}, pages = {571--580}, year = {2020}, doi = {10.5731/pdajpst.2019.010504}, publisher = {Parenteral Drug Association (PDA)}, abstract = {Microbiologists dread investigating results that are outside of the specifications. However, the investigation must be performed. A decision to reject the batch does not remove the requirement to investigate the failure. Unfortunately, microbiological assay samples are often consumed during the test or the results of the data are obtained several days after the sample is tested. This delay from testing to results often renders the original sample dilution not valid for further testing. Thus, this delay can hinder finding a root cause. Knowing the root cause can aid with microbial control, defining corrective actions, and defining preventative actions that are required to minimize or eliminate the potential for reoccurrence. The root cause is an essential component in understanding the patient impact, status of the product, and regulatory reporting requirements. This article discusses out of specification results obtained from the microbial examination of nonsterile product assays and the subsequent root cause investigation. The focus of this article is on aberrant results obtained from a validated assay with established acceptance criteria.}, issn = {1079-7440}, URL = {https://journal.pda.org/content/74/5/571}, eprint = {https://journal.pda.org/content/74/5/571.full.pdf}, journal = {PDA Journal of Pharmaceutical Science and Technology} }